Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
BeOne Medicines
Nurix Therapeutics, Inc.
Verismo Therapeutics
Regeneron Pharmaceuticals
AbbVie
Adicet Therapeutics
Genmab
Genmab
Novartis
Vironexis Biotherapeutics Inc.
AbbVie
Nurix Therapeutics, Inc.